Professor Sir Mark WALPORT
Prix Galien UK Committee Chair

2023 Prix Galien UK Award Winners

dropdown-iconBest Pharmaceutical Product

Jardiance® - Boehringer Ingelheim International GmbH

dropdown-iconBest Biotechnology Product

Zolgensma® - Novartis Pharmaceuticals UK Ltd.

Bimzelx® (bimekizumab) - UCB S.A.

dropdown-iconBest Medical Technology

Guardant360® CDx - Guardant Health

Idefirix® - Hansa Biopharma AB

dropdown-iconBest Digital Health Solution

Exscientia’s end-to-end AI-driven precision medicine platform -


dropdown-iconBest Public Sector Innovation

The Randomised Evaluation of COVID-19 Therapy [RECOVERY] clinical trial - University of Oxford

“The Prix Galien Awards Committee, who reviewed this year’s candidates and selected the award winners, were inspired by the work of the teams behind these innovations, which were developed to prevent, treat, and cure diseases,” said Professor Sir Mark Walport, Honorary Distinguished Professor of Medicine, Imperial College, and Prix Galien UK Committee Chair. “Congratulations to our winners and all award candidates, and thank you for your continued dedication to research and its applications for health improvement.”


Prix Galien UK 2023 Winners


Prix Galien UK 2023 Awards Ceremony

Preceding the Awards Ceremony, the Prix Galien UK Forum brought forth a day-long exchange on the most significant challenges facing humanity in the realm of disease while highlighting the latest research and clinical pathways toward diagnosis, treatment, and cure. An event not to be missed, the Prix Galien UK Forum brings together the brightest scientists, and industry researchers to exchange and offer their perspectives our shared future. Among the topics discussed in the 2023 edition of the forum:

  • Driving resilience in global medical supply chains
  • Access to innovation: Exploring solutions to global challenges
  • Impact of AI / Digital on healthcare
  • What is the role of the NHS in public sector innovation?
Prix Galien UK Awards Committee

The Prix Galien UK judging panel comprises numerous of the UK’s leading luminaries in healthcare. The distinguished panel is guided by the conviction that acknowledging research-driven innovation is key to the improvement of healthcare in the UK and human health globally.